Salmoporc Sow 20ml/20ds
Item No.90342

NAME OF THE VETERINARY MEDICINAL PRODUCT: Salmoporc lyophilisate and solvent for suspension for injection for pigs QUALITATIVE AND QUANTITATIVE COMPOSITION: Each dose (1 ml of the reconstituted vaccine) contains:Active substance: Salmonella Typhimurium mutant, strain 421/125,genetically-stable, doub
Description
NAME OF THE VETERINARY MEDICINAL PRODUCT: Salmoporc lyophilisate and solvent for suspension for injection for pigs
QUALITATIVE AND QUANTITATIVE COMPOSITION: Each dose (1 ml of the reconstituted vaccine) contains:Active substance: Salmonella Typhimurium mutant, strain 421/125,genetically-stable, double-attenuated(histidine-adenine auxotrophic)?5 x 108 to 5 x 109 CFU** Colony Forming Units.
PHARMACEUTICAL FORM Lyophilisate and solvent for suspension for injection White to yellow-brownish lyophilisate Clear colourless solvent
CLINICAL PARTICULARS 4.1 Target SpeciesPigs. Indications for use, specifying the target species. Subcutaneous use: For active immunisation of sows and gilts to reduce excretion of Salmonella typhimurium wild type strains during lactation.
Onset of immunity: two weeks after the second vaccination Duration of immunity: 24 weeks after the second vaccination Oral use: For active immunisation of suckling and weaned piglets to reduce bacterial colonisation and excretion as well as clinical symptoms due to an infection with Salmonella typhimurium. Onset of immunity: two weeks after the second vaccination.
Duration of immunity: 19 weeks after the second vaccination
QUALITATIVE AND QUANTITATIVE COMPOSITION: Each dose (1 ml of the reconstituted vaccine) contains:Active substance: Salmonella Typhimurium mutant, strain 421/125,genetically-stable, double-attenuated(histidine-adenine auxotrophic)?5 x 108 to 5 x 109 CFU** Colony Forming Units.
PHARMACEUTICAL FORM Lyophilisate and solvent for suspension for injection White to yellow-brownish lyophilisate Clear colourless solvent
CLINICAL PARTICULARS 4.1 Target SpeciesPigs. Indications for use, specifying the target species. Subcutaneous use: For active immunisation of sows and gilts to reduce excretion of Salmonella typhimurium wild type strains during lactation.
Onset of immunity: two weeks after the second vaccination Duration of immunity: 24 weeks after the second vaccination Oral use: For active immunisation of suckling and weaned piglets to reduce bacterial colonisation and excretion as well as clinical symptoms due to an infection with Salmonella typhimurium. Onset of immunity: two weeks after the second vaccination.
Duration of immunity: 19 weeks after the second vaccination
Specifications
- Species
- Swine
- Business Unit
- Swine
- HPRA SPC Link
- https://www.hpra.ie/img/uploaded/swedocuments/Licence_VPA10815-064-001_08122020130716.pdf
- Legal catagory
- POM
- Active/Ingredient(s)
- Salmonella Typhimurium mutant
- Licensing/Shipping
- This is a fridge product and can only be shipped Monday – Wednesday

Salmoporc Sow 20ml/20ds
Item No.90342
NAME OF THE VETERINARY MEDICINAL PRODUCT: Salmoporc lyophilisate and solvent for suspension for injection for pigs QUALITATIVE AND QUANTITATIVE COMPOSITION: Each dose (1 ml of the reconstituted vaccine) contains:Active substance: Salmonella Typhimurium mutant, strain 421/125,genetically-stable, doub
Description
NAME OF THE VETERINARY MEDICINAL PRODUCT: Salmoporc lyophilisate and solvent for suspension for injection for pigs
QUALITATIVE AND QUANTITATIVE COMPOSITION: Each dose (1 ml of the reconstituted vaccine) contains:Active substance: Salmonella Typhimurium mutant, strain 421/125,genetically-stable, double-attenuated(histidine-adenine auxotrophic)?5 x 108 to 5 x 109 CFU** Colony Forming Units.
PHARMACEUTICAL FORM Lyophilisate and solvent for suspension for injection White to yellow-brownish lyophilisate Clear colourless solvent
CLINICAL PARTICULARS 4.1 Target SpeciesPigs. Indications for use, specifying the target species. Subcutaneous use: For active immunisation of sows and gilts to reduce excretion of Salmonella typhimurium wild type strains during lactation.
Onset of immunity: two weeks after the second vaccination Duration of immunity: 24 weeks after the second vaccination Oral use: For active immunisation of suckling and weaned piglets to reduce bacterial colonisation and excretion as well as clinical symptoms due to an infection with Salmonella typhimurium. Onset of immunity: two weeks after the second vaccination.
Duration of immunity: 19 weeks after the second vaccination
QUALITATIVE AND QUANTITATIVE COMPOSITION: Each dose (1 ml of the reconstituted vaccine) contains:Active substance: Salmonella Typhimurium mutant, strain 421/125,genetically-stable, double-attenuated(histidine-adenine auxotrophic)?5 x 108 to 5 x 109 CFU** Colony Forming Units.
PHARMACEUTICAL FORM Lyophilisate and solvent for suspension for injection White to yellow-brownish lyophilisate Clear colourless solvent
CLINICAL PARTICULARS 4.1 Target SpeciesPigs. Indications for use, specifying the target species. Subcutaneous use: For active immunisation of sows and gilts to reduce excretion of Salmonella typhimurium wild type strains during lactation.
Onset of immunity: two weeks after the second vaccination Duration of immunity: 24 weeks after the second vaccination Oral use: For active immunisation of suckling and weaned piglets to reduce bacterial colonisation and excretion as well as clinical symptoms due to an infection with Salmonella typhimurium. Onset of immunity: two weeks after the second vaccination.
Duration of immunity: 19 weeks after the second vaccination
Specifications
- Species
- Swine
- Business Unit
- Swine
- HPRA SPC Link
- https://www.hpra.ie/img/uploaded/swedocuments/Licence_VPA10815-064-001_08122020130716.pdf
- Legal catagory
- POM
- Active/Ingredient(s)
- Salmonella Typhimurium mutant
- Licensing/Shipping
- This is a fridge product and can only be shipped Monday – Wednesday